Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Latest, FY2025
10,518
Period ended Dec 31, 2025
Change on a year earlier
+20.8%
8,706 in FY2024
History
15 years
Since FY2008
Sources
12
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other Current Assets ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 10,518 | +20.8% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 8,706 | +4.0% | Form 10-K (filed 2025-02-25) ↗ |
| FY2023 | Dec 31, 2023 | 8,368 | +16.7% | Form 10-K (filed 2024-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 7,169 | +2.6% | Form 10-K (filed 2023-02-24) ↗ |
| FY2021 | Dec 31, 2021 | 6,987 | +49.5% | Form 10-K (filed 2022-02-25) ↗ |
| FY2020 | Dec 31, 2020 | 4,674 | +9.3% | Form 10-K (filed 2022-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 4,277 | -5.0% | Form 10-K (filed 2020-02-26) ↗ |
| FY2018 | Dec 31, 2018 | 4,500 | +4.7% | Form 10-K (filed 2019-02-27) ↗ |
| FY2017 | Dec 31, 2017 | 4,299 | -2.1% | Form 10-K (filed 2018-02-27) ↗ |
| FY2016 | Dec 31, 2016 | 4,389 | -14.6% | SEC Filing ↗ |
| FY2015 | Dec 31, 2015 | 5,140 | +9.6% | SEC Filing ↗ |
| FY2014 | Dec 31, 2014 | 4,689 | – | Form 10-K (filed 2016-02-26) ↗ |
| FY2010 | Dec 31, 2010 | 3,651 | -12.6% | Form 10-K (filed 2011-02-28) ↗ |
| FY2009 | Dec 31, 2009 | 4,177 | -51.6% | Form 10-K (filed 2011-02-28) ↗ |
| FY2008 | Dec 31, 2008 | 8,628 | – | Form 10-K (filed 2010-03-01) ↗ |
Cite this data
StockData. (2026). Merck Other Current Assets ($M) ($M), annual FY2008–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_bal_oca
See every metric in the Merck KPI table. Data updated Oct 26, 2026.